Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Measure of the Plasma Tissue Factor Allow to Predict a Venous Thromboembolism Episode for Patients Presenting a Primitive Lung Cancer?

NCT02853188 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT02853188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02853188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Measure of the Plasma Tissue Factor Allow to Predict a Venous Thromboembolism Episode for Patients Presenting a Primitive Lung Cancer?
Lead sponsor
Hopital Foch
Phase
Not applicable
Overall status
Completed
Start date
December 4, 2014
Completion date
December 20, 2018
Enrollment
315 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of lung